SET2

Source: Wikipedia, the free encyclopedia.
SET2
Identifiers
  • N-(furan-2-ylmethyl)-3-({4-[methyl(propyl)amino]-6-(trifluoromethyl)pyrimidin-2-yl}sulfanyl)propanamide
JSmol)
  • O=C(CCSc1nc(cc(n1)N(C)CCC)C(F)(F)F)NCc2ccco2
  • InChI=1S/C17H21F3N4O2S/c1-3-7-24(2)14-10-13(17(18,19)20)22-16(23-14)27-9-6-15(25)21-11-12-5-4-8-26-12/h4-5,8,10H,3,6-7,9,11H2,1-2H3,(H,21,25)
  • Key:LZHSWRWIMQRTOP-UHFFFAOYSA-N

SET2 is a drug which acts as a selective

antagonist for the TRPV2 receptor. It is moderately potent with an IC50 of 460nM, but is highly selective for TRPV2 over the other subtypes of TRPV, and is the first such compound to be developed. A role has been suggested for TRPV2 in tumor metastasis, making this a target of interest in the treatment of cancer.[1]

See also

References

This page is based on the copyrighted Wikipedia article: SET2. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy